On the feasibility of designing new anti
โ
Roger M Pinder
๐
Article
๐
2001
๐
John Wiley and Sons
๐
English
โ 62 KB
Modern antidepressants lack many of the side-effects and much of the toxicity of the first generation tricyclics and monoamine oxidase inhibitors. Knowledge of the receptor interactions that are responsible for poor tolerability and potential lethality in overdosage has enabled the design of agents